
Serostim Boosts Bone Density, Cuts Fracture Risk in American Men with Osteoporosis
Reading Time: 3 minutes Introduction Osteoporosis, a condition characterized by weakened bones and increased risk of fractures, affects millions of Americans, including a significant number of men. Traditional treatments have focused on medications that slow bone loss, but recent research has shifted towards therapies that can actively promote bone formation. Serostim, a recombinant human growth hormone, has emerged as a promising agent in this regard. A groundbreaking study conducted across the United States, involving over 1,000 male participants, has provided crucial insights into the long-term effects of Serostim on bone density in men with osteoporosis. This article delves into the findings of this extensive...